We are live on ! Find out more
NHG

NQ HCIF GP Portfolio holdings

AUM $50.2M
1-Year Est. Return 45.53%
This Fund
S&P 500
This Quarter Est. Return
+22.37%
1 Year Est. Return
-45.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$64.2M
AUM Growth
+$11.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$64.2M 100%
3,096,650

Similar funds

NQ HCIF GP's Q1 2015 Portfolio in Review

As of Q1 2015, NQ HCIF GP held 1 position worth $64.2M, up 22% from $52.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 0%. NQ HCIF GP opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NQ HCIF GP's ten largest holdings make up 100% of its $64.2M portfolio in Q1 2015.
  • NQ HCIF GP opened 0 new positions and closed 0 in Q1 2015.
  • NQ HCIF GP's portfolio value rose 22% quarter-over-quarter to $64.2M.

Based on NQ HCIF GP's 13F filing for Q1 2015, filed 28 Apr 2015.